Industry Updates

The Industry Ministry has given its dissent note to the report of the high-level committee, which suggested that all FDI proposals for takeover of existing Indian pharmaceutical companies should be approved by competition watchdog CCI.

Cancer-drug shortages in the U.S. have caused hundreds of clinical trials to be stopped or delayed, threatening progress on new treatments, a top health official told Congress Friday.

With President Barack Obama and Congress professing seriousness about ending the era of annual trillion-dollar deficits and deflating the national debt once and for all, it wouldn’t appear to be the right time to seek additional tax breaks from Washington.